查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514895

瘧疾和鐮狀細胞疾病治療市場，按疾病、藥物類型、給藥途徑、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Malaria and Sickle Cell Disease Treatment Market, By Disease, By Drug Type, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年瘧疾和鐮狀細胞疾病治療市場規模為56.1136億美元，2024年至2032年複合年成長率為25.9%。

瘧疾和鐮狀細胞疾病治療市場-市場動態

瘧疾和鐮狀細胞疾病高發生率的治療進展

在瘧疾和鐮狀細胞疾病高盛行率的情況下，治療取得進展對於解決這些疾病造成的重大全球健康負擔至關重要。例如，根據世界衛生組織 (WHO) 的統計，瘧疾每年影響全球超過 2 億人。據鐮狀細胞疾病聯盟稱，全世界每年估計有 30 萬名兒童出生時患有鐮狀細胞疾病 (SCD)。到2050 年，這一數字預計將增加到40 萬。 。最近的突破包括他非諾喹等新型抗瘧藥物的批准，以及針對鐮狀細胞疾病的有前途的基因編輯療法的出現，凸顯了醫療保健領域的進步有可能減輕這些疾病對全世界受影響人群的負擔。

瘧疾和鐮狀細胞疾病治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 25.9% 左右的複合年成長率成長

根據疾病細分，鐮狀細胞疾病預計將在 2023 年顯示最大的市場佔有率

依藥品類型細分，2023年抗瘧藥為主導類型

按地區分類，亞太地區是 2023 年的主要收入來源

瘧疾和鐮狀細胞疾病治療市場-細分分析：

全球瘧疾和鐮狀細胞疾病治療市場根據疾病、藥物類型、給藥途徑和地區進行細分。

市場依疾病分為兩類：瘧疾和鐮狀細胞疾病。瘧疾優先考慮速效藥物來應對不斷增加的病例和抗藥性，並專注於高負擔地區。相反，鐮狀細胞片段的目標是長期管理慢性症狀和改善患者的生活品質。

根據藥物類型，市場分為三類：抗瘧藥物、疼痛管理藥物和疾病緩解療法。抗瘧藥物占主導地位，針對的是寄生蟲本身。疼痛管理藥物可解決鐮狀細胞疾病的關鍵症狀。最有前途的部分是疾病修飾療法，有可能減緩疾病進展並改善長期結果。

瘧疾和鐮狀細胞疾病治療市場 - 地理洞察

瘧疾和鐮狀細胞疾病治療市場表現出多種模式，重要活動集中在受這些疾病影響不成比例的地區，特別是撒哈拉以南非洲和東南亞部分地區。在非洲，瘧疾流行，鐮狀細胞病患疾病率很高，「減少瘧疾夥伴關係」和國家瘧疾控制計畫等措施推動了對治療和介入措施的需求。此外，改善醫療保健服務和加強醫療保健基礎設施的努力也有助於這些地區的市場成長。在東南亞，印度和印尼等國家正在努力應對嚴重的瘧疾負擔，而鐮狀細胞疾病仍然是印度和奈及利亞等人口眾多國家的問題。這些地區共同代表了瘧疾和鐮狀細胞疾病治療的主要市場，在對抗這些疾病和改善醫療保健的獲取和提供方面的持續努力推動了市場擴張的機會。

瘧疾與鐮狀細胞疾病治療市場-競爭格局：

瘧疾和鐮狀細胞疾病治療市場是輝瑞、諾華和賽諾菲等製藥巨頭的戰場。這些公司不斷創新以保持領先地位，採取的策略包括推出新藥（例如諾華公司的每日一次瘧疾治療藥物）、收購有前途的公司（例如輝瑞公司收購鐮狀細胞療法領導者Global Blood Therapeutics）以及大力投資研發下一代解決方案。這種激烈的競爭對患者來說是個好消息，因為它轉化為不斷改進的藥物、更簡單的治療方案，並有望實現解決這兩種疾病未被滿足的需求的突破。

最近的發展：

2022年9月，Vertex Pharmaceuticals和CRISPR Therapeutics推出了一種名為「exa-cel」的基因療法，用於治療鐮狀細胞疾病。這種治療涉及永久改變患者血細胞中的DNA，以幫助身體產生胎兒形式的血紅蛋白，這種血紅蛋白在出生時自然存在，但會轉變為成人形式，而成人形式在鐮狀細胞病患者中是有缺陷的。

2023 年 12 月，美國食品藥物管理局批准了兩種具有里程碑意義的治療方法 Casgevy 和 Lyfgenia，代表了第一種用於治療 12 歲及以上患者鐮狀細胞疾病 (SCD) 的細胞基因療法。

目錄

第1章：瘧疾和鐮狀細胞疾病治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 瘧疾和鐮狀細胞疾病治療市場按疾病分類的片段
    • 按藥物類型分類的瘧疾和鐮狀細胞疾病治療市場片段
    • 依給藥途徑分類的瘧疾和鐮狀細胞疾病治療市場片段
    • 按國家/地區分類的瘧疾和鐮狀細胞疾病治療市場片段
    • 按地區分類的瘧疾和鐮狀細胞疾病治療市場片段
  • 競爭洞察

第 3 章：瘧疾和鐮狀細胞疾病治療主要市場趨勢

  • 瘧疾和鐮狀細胞疾病治療市場促進因素
    • 市場促進因素的影響分析
  • 瘧疾和鐮狀細胞疾病治療市場限制
    • 市場限制影響分析
  • 瘧疾和鐮狀細胞疾病治療市場機會
  • 瘧疾和鐮狀細胞疾病治療市場未來趨勢

第 4 章：瘧疾和鐮狀細胞疾病治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：瘧疾和鐮狀細胞疾病治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：瘧疾和鐮狀細胞疾病治療市場格局

  • 2023 年瘧疾和鐮狀細胞疾病治療市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：瘧疾和鐮狀細胞疾病治療市場 - 按疾病分類

  • 概述
    • 按疾病分類的細分市場佔有率分析
    • 瘧疾
    • 鐮形血球貧血症

第 8 章：瘧疾和鐮狀細胞疾病治療市場 - 按藥物類型

  • 概述
    • 按藥物類型分類的細分市場佔有率分析
    • 抗瘧藥
    • 疼痛管理藥物
    • 疾病緩解療法
    • 其他

第 9 章：瘧疾和鐮狀細胞疾病治療市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 口服
    • 注射用

第 10 章：瘧疾和鐮狀細胞疾病治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美瘧疾和鐮狀細胞疾病治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按疾病）
    • 北美市場規模和預測（按藥物類型）
    • 北美市場規模與預測（按管理途徑）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲瘧疾和鐮狀細胞疾病治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按疾病）
    • 歐洲市場規模和預測（按藥物類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區瘧疾和鐮狀細胞疾病治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按疾病）
    • 亞太地區市場規模和預測（按藥物類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲瘧疾和鐮狀細胞疾病治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疾病）
    • 拉丁美洲市場規模與預測（按藥物類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲瘧疾和鐮狀細胞疾病治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疾病）
    • 中東和非洲市場規模及預測（按藥物類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 瘧疾和鐮狀細胞疾病治療產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc.
    • Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
    • Bluebird bio Inc.
    • Celgene Corporation (acquired by Bristol Myers Squibb)
    • Emmaus Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • MacroGenics, Inc.
    • Merck & Co., Inc.
    • Novartis International AG
    • Pfizer Inc.
    • Sanofi SA
    • Sobi
    • Vertex Pharmaceuticals Incorporated
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3025

REPORT HIGHLIGHT

Malaria and Sickle Cell Disease Treatment Market size was valued at USD 5,611.36 million in 2023, expanding at a CAGR of 25.9% from 2024 to 2032.

The Malaria and Sickle Cell Disease Treatment Market refers to the industry segment focused on the development and provision of therapies and interventions for combating malaria and managing sickle cell disease. The persistent global burden of malaria, particularly in tropical and subtropical regions, driving investments in research and development for innovative treatments and preventive measures. Additionally, the growing prevalence of sickle cell disease, especially in regions with high malaria transmission rates, further fuels market growth, prompting efforts to enhance disease management and develop curative therapies. However, restraints include the challenge of drug resistance in malaria treatment and the complexity of sickle cell disease management, compounded by limited access to healthcare in resource-constrained settings. Nevertheless, opportunities abound with advancements in precision medicine and gene therapy, promising novel approaches for personalized treatment and potential cures, thereby driving innovation and market expansion in the malaria and sickle cell disease treatment landscape.

Malaria and Sickle Cell Disease Treatment Market- Market Dynamics

Advancements in Treating Malaria and Sickle Cell Disease Amidst High Prevalence

Advancements in treating malaria and sickle cell disease amidst high prevalence are crucial for addressing the significant global health burden posed by these conditions. For instance, according to the World Health Organization (WHO), malaria affects over 200 million people worldwide annually. According to the Sickle Cell Disease Coalition, an estimated 300,000 children are born annually with sickle cell disease (SCD) worldwide. This number is expected to increase to 400,000 by 2050. In response, organizations like the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are investing in research initiatives aimed at developing innovative treatments and preventive strategies. Recent breakthroughs include the approval of new antimalarial drugs like tafenoquine and the emergence of promising gene-editing therapies for sickle cell disease, underscoring the potential of advancements in healthcare to alleviate the burden of these diseases on affected populations worldwide.

Malaria and Sickle Cell Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 25.9% over the forecast period (2024-2032)

Based on Disease segmentation, Sickle Cell Disease was predicted to show maximum market share in the year 2023

Based on Drug Type segmentation, Antimalarial Drugs was the leading type in 2023

Based on region, Asia Pacific was the leading revenue generator in 2023

Malaria and Sickle Cell Disease Treatment Market- Segmentation Analysis:

The Global Malaria and Sickle Cell Disease Treatment Market is segmented based on Disease, Drug Type, Route of Administration, and Region.

The market is divided into two categories based on Disease: Malaria and Sickle cell disease. Malaria prioritizes fast-acting drugs to combat rising cases and resistance, focusing on high-burden regions. Conversely, the sickle cell segment targets long-term management of chronic symptoms and improving patients' quality of life.

The market is divided into three categories based on Drug Type: Antimalarial Drugs, Pain Management Drugs, and Disease-Modifying Therapies. Antimalarial drugs dominate, targeting the parasite itself. Pain management drugs address a key symptom of sickle cell disease. The most promising segment is disease-modifying therapies, offering the potential to slow disease progression and improve long-term outcomes.

Malaria and Sickle Cell Disease Treatment Market- Geographical Insights

The Malaria and Sickle Cell Disease Treatment Market exhibits diverse patterns, with significant activity concentrated in regions disproportionately affected by these diseases, particularly in sub-Saharan Africa and parts of Southeast Asia. In Africa, where malaria is endemic and sickle cell disease prevalence is high, initiatives like the Roll Back Malaria Partnership and national malaria control programs drive demand for treatments and interventions. Additionally, efforts to improve access to healthcare and strengthen healthcare infrastructure contribute to market growth in these regions. In Southeast Asia, countries like India and Indonesia grapple with significant malaria burdens, while sickle cell disease remains a concern in countries with large populations such as India and Nigeria. These regions collectively represent key markets for malaria and sickle cell disease treatments, with opportunities for market expansion driven by ongoing efforts to combat these diseases and improve healthcare access and delivery.

Malaria and Sickle Cell Disease Treatment Market- Competitive Landscape:

The Malaria and Sickle Cell Disease treatment market is a battlefield for pharmaceutical giants like Pfizer, Novartis, and Sanofi. These companies are constantly innovating to stay ahead, with strategies like launching new drugs (e.g., Novartis' once-daily malaria treatment), acquiring promising companies (e.g., Pfizer's acquisition of sickle cell therapy leader Global Blood Therapeutics), and investing heavily in R&D for next-generation solutions. This fierce competition is good news for patients, as it translates into a constant flow of improved medications, easier treatment regimens, and hopefully, breakthroughs that address unmet needs in both diseases.

Recent Developments:

In September 2022, Vertex Pharmaceuticals and CRISPR Therapeutics launched a gene therapy called "exa-cel" for treating sickle cell disease. The treatment involves permanently changing DNA in a patient's blood cells to help the body produce a fetal form of hemoglobin, which is naturally present at birth but switches to an adult form that is defective in people with sickle cell disease.

In December 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)

Bluebird Bio Inc.

Celgene Corporation (acquired by Bristol Myers Squibb)

Emmaus Pharmaceuticals, Inc.

F. Hoffmann-La Roche Ltd

Gilead Sciences, Inc.

GlaxoSmithKline plc

Johnson & Johnson

MacroGenics, Inc.

Merck & Co., Inc.

Novartis International AG

Pfizer Inc.

Sanofi S.A.

Sobi

Vertex Pharmaceuticals Incorporated

Others

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Malaria
  • Sickle cell disease

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antimalarial Drugs
  • Pain Management Drugs
  • Disease-Modifying Therapies
  • Other

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Parenteral

GLOBAL MALARIA AND SICKLE CELL DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Malaria and Sickle Cell Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Malaria and Sickle Cell Disease Treatment Market Snippet by Disease
    • 2.1.2. Malaria and Sickle Cell Disease Treatment Market Snippet by Drug Type
    • 2.1.3. Malaria and Sickle Cell Disease Treatment Market Snippet by Route of Administration
    • 2.1.4. Malaria and Sickle Cell Disease Treatment Market Snippet by Country
    • 2.1.5. Malaria and Sickle Cell Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Malaria and Sickle Cell Disease Treatment Key Market Trends

  • 3.1. Malaria and Sickle Cell Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Malaria and Sickle Cell Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Malaria and Sickle Cell Disease Treatment Market Opportunities
  • 3.4. Malaria and Sickle Cell Disease Treatment Market Future Trends

4. Malaria and Sickle Cell Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Malaria and Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Malaria and Sickle Cell Disease Treatment Market Landscape

  • 6.1. Malaria and Sickle Cell Disease Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Malaria and Sickle Cell Disease Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 7.1.2. Malaria
    • 7.1.3. Sickle cell disease

8. Malaria and Sickle Cell Disease Treatment Market - By Drug Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
    • 8.1.2. Antimalarial Drugs
    • 8.1.3. Pain Management Drugs
    • 8.1.4. Disease-Modifying Therapies
    • 8.1.5. Other

9. Malaria and Sickle Cell Disease Treatment Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Parenteral

10. Malaria and Sickle Cell Disease Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Malaria and Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Malaria and Sickle Cell Disease Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Alexion Pharmaceuticals, Inc. (acquired by AstraZeneca)
    • 11.2.3. Bluebird bio Inc.
    • 11.2.4. Celgene Corporation (acquired by Bristol Myers Squibb)
    • 11.2.5. Emmaus Pharmaceuticals, Inc.
    • 11.2.6. F. Hoffmann-La Roche Ltd
    • 11.2.7. Gilead Sciences, Inc.
    • 11.2.8. GlaxoSmithKline plc
    • 11.2.9. Johnson & Johnson
    • 11.2.10. MacroGenics, Inc.
    • 11.2.11. Merck & Co., Inc.
    • 11.2.12. Novartis International AG
    • 11.2.13. Pfizer Inc.
    • 11.2.14. Sanofi S.A.
    • 11.2.15. Sobi
    • 11.2.16. Vertex Pharmaceuticals Incorporated
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Disease 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Drug Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Drug Type 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Malaria and Sickle Cell Disease Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Malaria and Sickle Cell Disease Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE North America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Europe Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Latin America Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Drug Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • FIGURE Malaria and Sickle Cell Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Disease segment market share analysis, 2023 & 2032
  • FIGURE Disease segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Type segment market share analysis, 2023 & 2032
  • FIGURE Drug Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2023 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Germany Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE India Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Brazil Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Malaria and Sickle Cell Disease Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Malaria and Sickle Cell Disease Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)